{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T18:08:01Z","timestamp":1766599681188},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T00:00:00Z","timestamp":1396396800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s40268-014-0040-1","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T14:24:45Z","timestamp":1396362285000},"page":"63-71","source":"Crossref","is-referenced-by-count":11,"title":["The Effects of Moxifloxacin on QTc Interval in Healthy Korean Male Subjects"],"prefix":"10.1007","volume":"14","author":[{"given":"Seol Ju","family":"Moon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jongtae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyungmi","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Seok","family":"Yim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Yong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Sang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo-Youn","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung Soo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,2]]},"reference":[{"key":"40_CR1","unstructured":"International Conference on Harmonisation. The clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs (ICH E14). ICH, Geneva, 12 May 2005. Available at: http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E14\/E14_Guideline.pdf Accessed 03 Jan 2014."},{"issue":"2","key":"40_CR2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0008-6363(00)00119-X","volume":"47","author":"W Haverkamp","year":"2000","unstructured":"Haverkamp W, Breithardt G, Camm AJ, et al. The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. Cardiovasc Res. 2000;47(2):219\u201333.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"40_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11319160-000000000-00000","volume":"33","author":"M Malik","year":"2010","unstructured":"Malik M, Garnett CE, Zhang J. Thorough QT studies: questions and quandaries. Drug Saf Int J Med Toxicol Drug Exp. 2010;33(1):1\u201314.","journal-title":"Drug Saf Int J Med Toxicol Drug Exp"},{"issue":"6","key":"40_CR4","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1067\/mcp.2000.111482","volume":"68","author":"JL Demolis","year":"2000","unstructured":"Demolis JL, Kubitza D, Tenneze L, Funck-Brentano C. Effect of a single oral dose of moxifloxacin (400\u00a0mg and 800\u00a0mg) on ventricular repolarization in healthy subjects. Clin Pharmacol Ther. 2000;68(6):658\u201366.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"40_CR5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2125.2012.04415.x","volume":"75","author":"RR Shah","year":"2013","unstructured":"Shah RR. Drug-induced QT interval prolongation: does ethnicity of the thorough QT study population matter? Br J Clin Pharmacol. 2013;75(2):347\u201358.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"40_CR6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/heart.87.3.220","volume":"87","author":"M Malik","year":"2002","unstructured":"Malik M, Farbom P, Batchvarov V, Hnatkova K, Camm AJ. Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval. Heart. 2002;87(3):220\u20138.","journal-title":"Heart"},{"issue":"6","key":"40_CR7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2125.2003.01791.x","volume":"55","author":"M Desai","year":"2003","unstructured":"Desai M, Li L, Desta Z, Malik M, Flockhart D. Variability of heart rate correction methods for the QT interval. Br J Clin Pharmacol. 2003;55(6):511\u20137.","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"40_CR8","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1177\/0091270010381498","volume":"51","author":"JA Florian","year":"2011","unstructured":"Florian JA, Tornoe CW, Brundage R, Parekh A, Garnett CE. Population pharmacokinetic and concentration-QTc models for moxifloxacin: pooled analysis of 20 thorough QT studies. J Clin Pharmacol. 2011;51(8):1152\u201362.","journal-title":"J Clin Pharmacol"},{"key":"40_CR9","unstructured":"International Conference on Harmonisation. E14 Implementation Working Group. ICH E14 Guideline: the clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs: questions and answers (R1). ICH, Geneva, 5 April 2012. Available at: http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E14\/E14_Q_As_R1_step4.pdf . Accessed 03 Jan 2014."},{"issue":"1","key":"40_CR10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bcp.12168","volume":"77","author":"J Taubel","year":"2014","unstructured":"Taubel J, Ferber G, Lorch U, Batchvarov V, Savelieva I, Camm AJ. Thorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjects. Br J Clin Pharmacol. 2014;77(1):170\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"40_CR11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2125.2006.02793.x","volume":"63","author":"JG Shin","year":"2007","unstructured":"Shin JG, Kang WK, Shon JH, et al. Possible interethnic differences in quinidine-induced QT prolongation between healthy Caucasian and Korean subjects. Br J Clin Pharmacol. 2007;63(2):206\u201315.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"40_CR12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/10543400903581945","volume":"20","author":"LK Yan","year":"2010","unstructured":"Yan LK, Zhang J, Ng MJ, Dang Q. Statistical characteristics of moxifloxacin-induced QTc effect. J Biopharm Stat. 2010;20(3):497\u2013507.","journal-title":"J Biopharm Stat"}],"container-title":["Drugs in R&amp;D"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40268-014-0040-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-014-0040-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-014-0040-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T18:12:29Z","timestamp":1551204749000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40268-014-0040-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,2]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["40"],"URL":"https:\/\/doi.org\/10.1007\/s40268-014-0040-1","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"value":"1174-5886","type":"print"},{"value":"1179-6901","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,2]]}}}